Following the success of our Startup Creasphere APAC Batch 0 program, we have launched Batch 1 of our Startup Creasphere APAC program in Singapore. Our Startup Creasphere APAC program is modeled after our successful Startup Creasphere platform in Munich and aims to transform healthcare in the Asia Pacific together with our corporate partner, Roche.
The 4 selected startups selected by Roche are from Singapore, India, China and Switzerland, and are focusing on women’s fertility, ophthalmology and diabetes care.
Ava provides AI-driven and clinically validated digital therapeutics and diagnostics in the women's health space.
TeleMedC is a diagnostic imaging solutions company that uses sophisticated retinal imaging. Their primary objective is to provide low-cost diagnostic solutions for point-of-care screening and virtual management of eye and chronic diseases throughout the world.
Fitterfly provides innovative and integrated wellness programs with the sole mission to help people live healthier lives.
Gemii Technology is a private domain expert deeply engaged in the enterprise WeChat ecosystem and boosts the digital upgrade of industrial services with AI and SaaS products and operation services.
For more information about Startup Creasphere, please visit: https://startupcreasphere.com/
About Plug and Play
Plug and Play is a global innovation platform. Headquartered in Silicon Valley, we have built accelerator programs, corporate innovation services, and an in-house VC to make technological advancement progress faster than ever before. Since inception in 2006, our programs have expanded worldwide to include a presence in over 30 locations globally giving startups the necessary resources to succeed in Silicon Valley and beyond. With over 30,000 startups and 400 official corporate partners, we have created the ultimate startup ecosystem in many industries. Companies in our community have raised over $9 billion in funding, with successful portfolio exits including Danger, Rappi, Dropbox, Lending Club and PayPal.
For more information, reach out to us here!
